Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
432,001,939
-
Total 13F shares
-
260,736,943
-
Share change
-
+13,918,217
-
Total reported value
-
$9,423,303,775
-
Put/Call ratio
-
29%
-
Price per share
-
$36.14
-
Number of holders
-
221
-
Value change
-
+$494,381,045
-
Number of buys
-
115
-
Number of sells
-
111
Institutional Holders of Royalty Pharma plc - Common Stock (RPRX) as of Q3 2021
As of 30 Sep 2021 Royalty Pharma plc - Common Stock (RPRX) had 221 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 260,736,943 shares of stock of the company.
Largest 10 holders included MORGAN STANLEY, VANGUARD GROUP INC, ADAGE CAPITAL PARTNERS GP, L.L.C., FMR LLC, BlackRock Inc., Berkshire Hathaway Inc, Vantage Consulting Group Inc, HARVARD MANAGEMENT CO INC, SIGULER GUFF ADVISERS, LLC, and STATE STREET CORP.
This table shows 224 institutional shareholders of the security as of 30 Sep 2021.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.